Q2 2024
|
3 |
33,539 |
COHERUS BIOSCIENCES INC, BIOR, PBYI
|
13F-HR
|
8/8/2024 |
000112329224000213 |
Q1 2024
|
3 |
72,784 |
Omeros Corp, BIOR, PBYI
|
13F-HR
|
5/16/2024 |
000112329224000137 |
Q4 2023
|
3 |
68,826 |
Omeros Corp, BIOR, PBYI
|
13F-HR
|
2/14/2024 |
000112329224000048 |
Q3 2023
|
6 |
113,555 |
Omeros Corp, Biora Inc., BIOR, PBYI
|
13F-HR
|
11/14/2023 |
000112329223000142 |
Q2 2023
|
7 |
154,146 |
Omeros Corp, Biora Inc., Paratek Pharmaceuticals Inc., RVLP
|
13F-HR
|
8/14/2023 |
000112329223000094 |
Q1 2023
|
8 |
279,118 |
AMYT, Biora Inc., Omeros Corp, RVLP
|
RESTATEMENT
|
5/16/2023 |
000112329223000059 |
Q4 2022
|
11 |
237,928 |
AMYT, Biora Inc., Omeros Corp, RVLP
|
13F-HR
|
2/14/2023 |
000156761923002883 |
Q3 2022
|
11 |
267,004 |
Biora Inc., AMYT, Omeros Corp, CMAX
|
13F-HR
|
11/14/2022 |
000156761922020018 |
Q2 2022
|
11 |
237,754 |
Biora Inc., AMYT, Omeros Corp, BIOR
|
13F-HR
|
8/15/2022 |
000156761922016220 |
Q1 2022
|
10 |
281,299 |
Progenity Inc., AMYT, BIOR, Omeros Corp
|
13F-HR
|
5/16/2022 |
000156761922010942 |
Q4 2021
|
6 |
280,491 |
AMYT, Progenity Inc., BIOR, CMAX
|
13F-HR
|
2/14/2022 |
000156761922004383 |
Q3 2021
|
4 |
157,650 |
BIOR, AMYT, CMAX, SCTL
|
13F-HR
|
11/15/2021 |
000156761921020429 |
Q2 2021
|
4 |
239,861 |
BIOR, AMYT, CMAX, SCTL
|
13F-HR
|
8/16/2021 |
000156761921015856 |
Q1 2021
|
3 |
197,779 |
BIOR, AMYT, SCTL
|
13F-HR
|
5/17/2021 |
000156761921010489 |
Q4 2020
|
2 |
207,540 |
BIOR, AMYT
|
13F-HR
|
2/16/2021 |
000156761921004054 |
Q3 2019
|
1 |
5,073 |
KALA
|
13F-HR
|
11/14/2019 |
000156761919021532 |
Q2 2019
|
1 |
8,507 |
KALA
|
13F-HR
|
8/14/2019 |
000156761919016973 |
Q1 2019
|
2 |
97,853 |
AEGERION PHARMACEUTICALS INC, KALA
|
13F-HR
|
5/15/2019 |
000156761919011205 |
Q4 2018
|
3 |
103,805 |
AEGERION PHARMACEUTICALS INC, PTC THERAPEUTICS INC, KALA
|
13F-HR
|
2/12/2019 |
000156761919003291 |
Q3 2018
|
3 |
125,186 |
AEGERION PHARMACEUTICALS INC, PTC THERAPEUTICS INC, APEN
|
13F-HR
|
11/13/2018 |
000156761918005817 |
Q2 2018
|
3 |
92,483 |
AEGERION PHARMACEUTICALS INC, PTC THERAPEUTICS INC, APEN
|
13F-HR
|
8/14/2018 |
000156761918001098 |
Q1 2018
|
4 |
163,302 |
AEGERION PHARMACEUTICALS INC, VIVUS INC, PTC THERAPEUTICS INC, APEN
|
13F-HR
|
5/15/2018 |
000114036118023961 |
Q4 2017
|
5 |
169,055 |
AEGERION PHARMACEUTICALS INC, VIVUS INC, PTC THERAPEUTICS INC, SUCAMPO PHARMACEUTICALS INC
|
13F-HR
|
2/14/2018 |
000114036118007635 |